Skip to main content
SpringerLink
Log in

PPI use increases risk of liver-related adverse outcomes in cirrhosis

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Mahmud N, et al. The Association between Proton Pump Inhibitor Exposure and Key Liver-Related Outcomes in Patients with Cirrhosis: A Veterans Affairs Cohort Study Gastroenterology : 6 Apr 2022. Available from: URL: http://doi.org/10.1053/j.gastro.2022.03.052

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

PPI use increases risk of liver-related adverse outcomes in cirrhosis. Reactions Weekly 1903, 11 (2022). https://doi.org/10.1007/s40278-022-13573-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-13573-0

Search

Navigation